Financhill
Buy
76

EIF.TO Quote, Financials, Valuation and Earnings

Last price:
$82.61
Seasonality move :
2.5%
Day range:
$79.82 - $80.51
52-week range:
$45.00 - $83.13
Dividend yield:
3.29%
P/E ratio:
30.83x
P/S ratio:
1.45x
P/B ratio:
2.66x
Volume:
54K
Avg. volume:
134.8K
1-year change:
42.8%
Market cap:
$4.4B
Revenue:
$2.7B
EPS (TTM):
$2.61

EIF.TO Analysts' Consensus Rating

The 8 analysts providing 12-month price projections for Exchange Income Corp. shares anticipate an average target of $90.23, ranging from a low estimate of $80.00 to a high estimate of $100.00. This average target implies a growth of 12.07% compared to the current stock price of $80.51.

Consensus Price Target

$90.23

Highest Price Target

$100.00

Lowest Price Target

$80.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 7 7 7

Hold 0 1 1

Sell 0 0 0
Consensus Buy Buy Buy

EIF.TO Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is down 4.73% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is up 7.57% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is down 7.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock